Skip to main navigation Skip to search Skip to main content

Moving beyond hydroxychloroquine: The novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Research output: Contribution to journal › Comment/debate › peer-review

Original languageEnglish (US)
Article number72
JournalCancer Communications
Volume39
Issue number1
DOIs
StatePublished - Nov 9 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this